|
🐜
|
Personality traits in early phases of panic disorder: implications on the presence of agoraphobia, clinical severity and short‐term outcome
8 auth.
M. Carrera,
A. Herrán,
M. L. Ramírez,
A. Ayestarán,
D. Sierra‐Biddle,
F. Hoyuela,
...
B. Rodríguez-Cabo,
J. Vázquez-Barquero
|
5 |
2006 |
5
🐜
|
|
🐜
|
Quality of life in early phases of panic disorder: predictive factors.
9 auth.
M. Carrera,
A. Herrán,
J. Ayuso-Mateos,
D. Sierra‐Biddle,
M. L. Ramírez,
A. Ayestarán,
...
F. Hoyuela,
B. Rodríguez-Cabo,
J. Vázquez-Barquero
|
5 |
2006 |
5
🐜
|
|
🐢
|
An association between clotting factor concentrates use and mortality in human immunodeficiency virus-infected hemophilic patients.
7 auth.
J. Montoro,
J. Oliveras,
J. Lorenzo,
J. Tusell,
C. Altisent,
R. Molina,
...
A. Ayestarán
|
4 |
1995 |
4
🐢
|
|
🐬
|
Stability of amphotericin B in an extemporaneously prepared i.v. fat emulsion.
R. López,
A. Ayestarán,
L. Pou,
J. Montoro,
M. Hernández,
I. Caragol
|
3 |
1996 |
3
🐬
|
|
🐜
|
Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.
9 auth.
A. Herrán,
M. L. Ramírez,
M. Carrera,
M. García-Unzueta,
D. Sierra‐Biddle,
B. Rodríguez-Cabo,
...
A. Ayestarán,
F. Hoyuela,
J. Vázquez-Barquero
|
3 |
2006 |
3
🐜
|
|
🐬
|
Stability studies of binary and ternary mixtures containing morphine, midazolam, levomepromazine and hyoscine butylbromide for parenteral administration
F. Fernández-Campos,
Mireia Mallandrich,
A. Calpena,
A. Ayestarán,
C. Lacasa
|
2 |
2013 |
2
🐬
|
|
🐜
|
Panic disorder and the onset of agoraphobia
8 auth.
A. Herrán,
M. Carrera,
D. Sierra‐Biddle,
L. Ramírez,
B. Rodríguez-Cabo,
A. Ayestarán,
...
F. Hoyuela,
J. Vázquez-Barquero
|
0 |
2006 |
0
🐜
|
